Infectious Diseases News and Research

RSS

'African eye worm' hampers efforts to eliminate river blindness, study shows

Efforts to eliminate river blindness, a debilitating disease affecting millions in Africa, will be hampered by another parasitic infection known as Loiasis, or 'African eye worm,' according to a study published in Clinical Infectious Diseases.

20 Nov 2019

ETVAX vaccine candidate shows promise against enterotoxigenic E. coli diarrhea

University of Gothenburg reports first successful results of the oral, inactivated vaccine candidate ETVAX against enterotoxigenic E. coli diarrhea in a placebo-controlled phase I/II study in infants and children from 6 months to 5 years of age in Bangladesh.

20 Nov 2019

Depression puts teen girls in South Africa at higher risk of HIV infection

Teen girls in South Africa face an extraordinary threat of HIV: By the time they reach adulthood, one in four South African girls will have contracted the virus, and most are first infected during adolescence.

19 Nov 2019

New database helps identify therapeutic targets to fight infectious diseases

Infectious diseases are caused by pathogenic microorganisms capable of entering, colonizing and growing within a host organism, thus producing an infection. Bacterial infections have been on the rise worldwide in recent years, but many mechanisms underlying bacterial pathogenesis are still poorly understood.

19 Nov 2019

Tailored T-cells safe, may be effective in preventing and treating multiple viral infections

Tailored T-cells specially designed to combat a half dozen viruses are safe and may be effective in preventing and treating multiple viral infections, according to research led by Children's National Hospital faculty.

18 Nov 2019

Children born to women on HIV therapy more likely to have microcephaly, developmental delays

Children born to women on HIV therapy containing the drug efavirenz were 2 to 2.5 times more likely to have microcephaly, or small head size, compared to children born to women on regimens of other antiretroviral drugs, according to an analysis funded by the National Institutes of Health.

18 Nov 2019

'Dysbiosis' promotes the onset of colorectal cancer

The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti - holder of the Microbiology and Infectious Diseases Chair at the Collège de France -, have demonstrated that an imbalance in the gut microbiota, also known as "dysbiosis", promotes the onset of colorectal cancer.

18 Nov 2019

BGU researchers discover gene that causes nighttime atrial fibrillation

Genetic studies spanning three generations of a Persian Jewish family by researchers at Ben-Gurion University of the Negev. have identified a gene that causes nighttime atrial fibrillation (AFib).

18 Nov 2019

New CDC report raises concern over growing threat of antibiotic resistance

In the US, antibiotic-resistant germs are making millions sick and killing tens of thousands, according to new CDC report.

18 Nov 2019

New clinical guideline for treatment of drug-resistant tuberculosis published

The American Thoracic Society, Centers for Disease Control and Prevention, European Respiratory Society and the Infectious Diseases Society of America have published an official clinical guideline on the treatment of drug-resistant tuberculosis in the Nov. 15 American Journal of Respiratory and Critical Care Medicine.

18 Nov 2019

New NIH funding will accelerate progress in TB vaccine development

Seattle Children's Research Institute is one of three recipients of $30 million in first-year-funding provided by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to establish centers for immunology research to accelerate progress in tuberculosis vaccine development.

15 Nov 2019

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

A team of researchers in the Department of Microbiology, Immunology and Pathology at Colorado State University aim to advance what is known about the complex immune response necessary to prevent tuberculosis disease.

15 Nov 2019

Study provides new insights into potential outcomes of Zika virus infection

Using a relevant animal model (pigs), University of Saskatchewan researchers have shown that mild Zika virus infection in fetuses can cause abnormal brain development in apparently healthy young animals.

15 Nov 2019

Access to mobile phone location data can help understand spread of vector-borne diseases

Researchers from EPFL and MIT have shown that human mobility is a major factor in the spread of vector-borne diseases such as malaria and dengue even over short intra-city distances. In a paper published in Scientific Reports, the team compares different mobility models and concludes that having access to mobile phone location data can prove crucial in understanding disease transmission dynamics - and, ultimately, in stopping an outbreak from evolving into an epidemic.

15 Nov 2019

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

The National Institute of Allergy and Infectious Diseases has awarded Integral Molecular a contract (75N93019C00073) which will provide up to $5.5M over the next five years to define antibody responses to pathogenic viruses including Zika, Marburg and equine encephalitis viruses, aiding the discovery of vaccines and therapeutics against these currently untreatable and often lethal viruses.

14 Nov 2019

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

The Antibiotic Resistance Threats Report released by the U.S. Centers for Disease Prevention and Control today shows that while recent federal investments to combat antibiotic resistance have had meaningful impacts, the continued spread of infections that are not effectively treated by existing medicines pose deadly threats to patients and public health.

14 Nov 2019

Study sheds light on how HIV infection may increase risk for sudden cardiac death

The success of antiretroviral therapies has extended the lives of people living with HIV, long enough for other chronic health conditions to emerge, including a recently documented uptick in sudden death.

14 Nov 2019

Russian scientists explain how an additional component can triple vaccine efficiency

A team of Russian scientists carried out a study on the cell immunity level and found out how an adjuvant called azoximer bromide increases the immunogenicity of the anti-flu vaccine.

12 Nov 2019

New study sounds a note of caution in using probiotics in ICU

It's become common for patients in the intensive care unit (ICU), both children and adults, to receive probiotics. Often, they are started at home to counteract diarrhea caused by antibiotics. There is also interest in using probiotics proactively in the ICU. A large multicenter clinical trial in Canada is testing whether probiotics would prevent ventilator-associated pneumonia in adult ICU patients.

12 Nov 2019

Vaccine decreases chances of severe pneumonia in children

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

12 Nov 2019

Infectious Diseases News and Research

'African eye worm' hampers efforts to eliminate river blindness, study shows

ETVAX vaccine candidate shows promise against enterotoxigenic E. coli diarrhea

Depression puts teen girls in South Africa at higher risk of HIV infection

New database helps identify therapeutic targets to fight infectious diseases

Tailored T-cells safe, may be effective in preventing and treating multiple viral infections

Children born to women on HIV therapy more likely to have microcephaly, developmental delays

'Dysbiosis' promotes the onset of colorectal cancer

BGU researchers discover gene that causes nighttime atrial fibrillation

New CDC report raises concern over growing threat of antibiotic resistance

New clinical guideline for treatment of drug-resistant tuberculosis published

New NIH funding will accelerate progress in TB vaccine development

CSU awarded $1.2 million subcontract to accelerate tuberculosis vaccine development

Study provides new insights into potential outcomes of Zika virus infection

Access to mobile phone location data can help understand spread of vector-borne diseases

Integral Molecular receives NIH contract for $5.5 million to advance vaccine discovery

Antibiotic Resistance Threats report highlights significant gaps and impact of federal investments

Study sheds light on how HIV infection may increase risk for sudden cardiac death

Russian scientists explain how an additional component can triple vaccine efficiency

New study sounds a note of caution in using probiotics in ICU

Vaccine decreases chances of severe pneumonia in children

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News